Journal Article Summary
The article investigates the effectiveness of two non-invasive treatments—Extracorporeal Shock Wave Therapy (ECSWT) and phonophoresis therapy—on patients suffering from neck myofascial pain syndrome (MPS). This topic is significant because neck pain is a prevalent issue worldwide, leading to considerable disability and economic costs. MPS, characterized by painful trigger points in the muscles, is a common cause of neck pain, and finding effective treatments is essential for improving patients' quality of life and reducing healthcare burdens.
In the study, 40 patients with neck MPS were randomly assigned to receive either ECSWT or phonophoresis therapy over three weeks. Both groups also participated in a stretching exercise program and received medication. The results showed that both treatments significantly reduced pain and neck disability immediately after treatment and four weeks later. However, the ECSWT group experienced a more substantial and longer-lasting reduction in pain and disability compared to the phonophoresis group after the follow-up period.
Despite the positive findings, the study has limitations, including a lack of control groups and potential variability in patient adherence to the exercise program. These factors could affect the reliability of the results. Patients should consult with their healthcare providers to discuss these treatment options, considering their individual circumstances and the potential benefits and risks associated with ECSWT and phonophoresis therapy for managing neck pain.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Taheri Parisa, Naderi Marzie, Khosravi Saeid. Extracorporeal Shock Wave Therapy Versus Phonophoresis Therapy for Neck Myofascial Pain Syndrome: A Randomized Clinical Trial. Anesthesiology and Pain Medicine 2021. DOI: 10.5812/aapm.112592. PMID: 34336620. PMCID: PMC8314093.
Featured Pill Pals Product
Tizanidine 2 mg Capsules --- Generic For Zanaflex --- Ascend
Tizanidine 2 mg Capsules — Generic For Zanaflex — Ascend is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
